FDA approves second drug in new class of cholesterol-lowering medications

The U.S. Food and Drug Administration on Thursday approved a second drug that’s part of a potent new class of medications that sharply cut levels of “bad” LDL cholesterol. Repatha , an injectable drug, works by blocking a protein that interferes with the liver’s ability to remove LDL cholesterol from the blood.